Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center-Reference-Cited by-同舟云学术

Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center

Published:2019-01 Issue:1 Volume:73 Page:79-87
ISSN:0196-0644
Container-title:Annals of Emergency Medicine
language:en
Short-container-title:Annals of Emergency Medicine

Author:

El Majzoub Imad,Qdaisat Aiham,Thein Kyaw Z.,Win Myint A.,Han Myat M.,Jacobson Kalen,Chaftari Patrick S.,Prejean Michael,Reyes-Gibby Cielito,Yeung Sai-Ching J.^ORCID

Publisher

Elsevier BV

Subject

Emergency Medicine

Reference46 articles.

1. Emerging targets in cancer immunotherapy;Burugu;Semin Cancer Biol,2017

2. PD-1 and PD-L1 antibodies in cancer: current status and future directions;Balar;Cancer Immunol Immunother,2017

3. Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy;Zhao;Pharmacol Ther,2018

4. Intrinsic resistance of solid tumors to immune checkpoint blockade therapy;Zhao;Cancer Res,2017

5. Immune checkpoint inhibitors: new strategies to checkmate cancer;Wilson;Clin Exp Immunol,2017

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab;Supportive Care in Cancer;2024-09-09

2. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review;Diagnostics;2024-08-16

3. Management and outcome of oncological patients under immune checkpoint inhibitors presenting at the emergency department;Emergency Medicine Journal;2024-04-30

5. Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center;Cancers;2024-01-15